AAH arana therapeutics limited

There are no certainties that the offer will succeed . Cephalon...

  1. 7,809 Posts.
    There are no certainties that the offer will succeed . Cephalon offered to T/O SRX years ago for $5 but failed in the bid by 1% only . At the time of the offer SRX was making no income . Now SRX is growing at a rapid rate and earning a packet with no debt - but the sp of SRX is $2.22, less than half the T/O offer .....That is one Bio that is going to rumble one day .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.